~13 spots leftby Mar 2026

Digital Health Intervention for Graft-versus-Host Disease

Palo Alto (17 mi)
Overseen byLara Traeger, PhD
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: University of Miami
No Placebo Group

Trial Summary

What is the purpose of this trial?The goal of this interventional study is to learn if the Horizons mobile application is feasible for survivors of allogeneic hematopoietic stem cell transplant who have chronic graft-versus-host disease. Participants will be asked to complete surveys and use the Horizons mobile application.

Eligibility Criteria

This trial is for survivors of allogeneic hematopoietic stem cell transplant who are living with chronic graft-versus-host disease. Participants should be willing to complete surveys and use the Horizons mobile application.

Inclusion Criteria

I have had a stem cell transplant from a donor.
I have moderate to severe chronic graft-versus-host disease.

Treatment Details

The study is testing whether the Horizons app can help improve quality of life for people with chronic graft-versus-host disease after a stem cell transplant. It involves using the app and completing surveys about their experience.
1Treatment groups
Experimental Treatment
Group I: Horizons Digital Health Application GroupExperimental Treatment1 Intervention
Participants will receive the Horizons mobile application for up to 6 weeks.

Find a clinic near you

Research locations nearbySelect from list below to view details:
University of MiamiMiami, FL
Loading ...

Who is running the clinical trial?

University of MiamiLead Sponsor

References